Tenders Are Invited For Pharmaceutical Products – Successive Deliveries Of Radium Dichloride – 223 And Lutetium Oxodotreotide Lu – 177 To The Department Of Nuclear Medicine
Tenders Are Invited For Pharmaceutical Products – Successive Deliveries Of Radium Dichloride – 223 And Lutetium Oxodotreotide Lu – 177 To The Department Of Nuclear Medicine
Pharmaceutical Products – Successive Deliveries Of Radium Dichloride – 223 And Lutetium Oxodotreotide Lu – 177 To The Department Of Nuclear Medicine. Task 1 - Successive Deliveries Of Radium-223 Dichloride, Used In The Treatment Of Castration-Resistant Prostate Cancer, To The Department Of Nuclear Medicine,,Task 2 - Successive Deliveries Of Lutetium Lu-177 Oxodotreotide, Used In The Treatment Of Neuroendocrine Tumors Of The Digestive System, To The Department Of Nuclear Medicine
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
